EFFICACY OF PEGYLATED INTERFERON IN TREATMENT-EXPERIENCED CHINESE PATIENTS WITH HBEAG POSITIVE CHRONIC HEPATITIS B (BRIEF REPORT)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

XIONG YUE LI; LI HU; LIU FEN; ZHANG DAZHI; REN HONG; HU PENG

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2016 | Volume:16 | Issue:4 Page(s): 0-0

Download Full-Text

View:

332

Download:

219

Cites:

Information Journal Paper

Title

EFFICACY OF PEGYLATED INTERFERON IN TREATMENT-EXPERIENCED CHINESE PATIENTS WITH HBEAG POSITIVE CHRONIC HEPATITIS B (BRIEF REPORT)

Author(s)

Keywords

CHRONIC HEPATITIS B

PEGYLATED INTERFERON

TREATMENT-EXPERIENCED

NUCLEOT (S) IDE ANALOGUES

Abstract

Background: After treatment cessation, a high prevalence of relapse was reported in CHRONIC HEPATITIS B (CHB) patients in China, especially in nucleot (s) ide analogues (NUCs) -experienced patients. Re-treatment for these patients remains unsolved.Objectives: This study aims to evaluate the efficacy of PEGYLATED INTERFERON in HBeAg positive patients with exposure to antiviral therapy.Patients and Methods: A total of 55 TREATMENT-EXPERIENCED, HBeAg positive Chinese patients were enrolled in this study. Of these patients, 33 were NUCs-experienced and 22 were interferon-experienced. PEGYLATED INTERFERON was administered to 34 patients; and 21 patients were retreated with conventional interferon.Results: Of the 34 TREATMENT-EXPERIENCED patients who received PEGYLATED INTERFERON, 52.9% achieved virologic response, and 41.2% achieved HBeAg loss and seroconversion. Patients who were treated with PEGYLATED INTERFERON for 48 weeks achieved higher virologic response (80%); HBeAg loss (60%); HBeAg seroconversion (60%); and HBsAg loss (5%) than patients treated for 24 weeks with PEGYLATED INTERFERON. Their responses were also higher than those who were treated with conventional interferon. HBeAg seroconversion in TREATMENT-EXPERIENCED patients was independently associated with 48-week PEGYLATED INTERFERON therapy duration.Conclusions: PEGYLATED INTERFERON was effective in TREATMENT-EXPERIENCED patients with HBeAg positive CHB, and showed higher rates of virological response, HBeAg loss, and seroconversion. The results provide important information regarding the role of retreatment with PEGYLATED INTERFERON in TREATMENT-EXPERIENCED HBeAg positive patients.

Cites

No record.

References

No record.

Cite

APA: Copy

XIONG, YUE LI, LI, HU, LIU, FEN, ZHANG, DAZHI, REN, HONG, & HU, PENG. (2016). EFFICACY OF PEGYLATED INTERFERON IN TREATMENT-EXPERIENCED CHINESE PATIENTS WITH HBEAG POSITIVE CHRONIC HEPATITIS B (BRIEF REPORT). HEPATITIS MONTHLY, 16(4), 0-0. SID. https://sid.ir/paper/306990/en

Vancouver: Copy

XIONG YUE LI, LI HU, LIU FEN, ZHANG DAZHI, REN HONG, HU PENG. EFFICACY OF PEGYLATED INTERFERON IN TREATMENT-EXPERIENCED CHINESE PATIENTS WITH HBEAG POSITIVE CHRONIC HEPATITIS B (BRIEF REPORT). HEPATITIS MONTHLY[Internet]. 2016;16(4):0-0. Available from: https://sid.ir/paper/306990/en

IEEE: Copy

YUE LI XIONG, HU LI, FEN LIU, DAZHI ZHANG, HONG REN, and PENG HU, “EFFICACY OF PEGYLATED INTERFERON IN TREATMENT-EXPERIENCED CHINESE PATIENTS WITH HBEAG POSITIVE CHRONIC HEPATITIS B (BRIEF REPORT),” HEPATITIS MONTHLY, vol. 16, no. 4, pp. 0–0, 2016, [Online]. Available: https://sid.ir/paper/306990/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops